Every week, discover in a precise and easy way how your business has been impacted by the recent developments in the pharma & biotech industry. Subscribe!
Every week, our team of analysts and writers is proud to provide more than 4,500 subscribers with up-to-date news, covering Corporate, CDMOs, R&D, and regulatory news.
New merger in the early-phase CDMO industry.
18th of September, 2017
Larka's newsletter covers CDMOs latest news, as well as corporate, regulatory and trials recent developments.
Sign up with your name and email address to receive news and updates.
Canadian spin off, Chinese acquirer.
11th of September, 2017
India's still in US FDA's sights.
4th of September, 2017
Bio CDMO landscape is moving fast.
28th of August, 2017
New merger in the bio-manufacturing industry.
21st of August, 2017
API market still reshapes
14th of August, 2017
New player enters the game.
7th of August, 2017
No summer break for supply contracts.
31st of July, 2017
Opiates production industry still on the move.
24th of July, 2017
Amatsi acquired by Eurofins Labs.
17th of July, 2017
New quality issues for Asian API
10th of July, 2017
New option for oligonucleotide manufacturing.
3rd of July, 2017
Big Pharma keeps shifting towards biologics.
26th of June, 2017
Dr. Reddy's: 1 down, 4 to go.
19th of June, 2017
Roquette sets foot in Brazil.
12th of June, 2017
CDMOs close dev agreements.
5th of June, 2017
US gets FDA clearance, China gets a warning.
29th of May, 2017